PF-04634817 succinate

Names

[ Name ]:
PF-04634817 succinate

Biological Activity

[Description]:

PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. Other Indication Phase 2 Discontinued

[References]

References View Related Products by Target Chemokine Receptor (CCR and CXCR) Other Indication

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₅H₃₆F₃N₅O₃·C₄H₆O₄

[ Molecular Weight ]:
629.67

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.